文献速递术前评估与围术期医学

地氟烷与七氟烷术后呼吸系统并发症比较:单中心队列研究

A comparison of postoperative respiratory complications associated with the use of desflurane and sevoflurane: a single-centre cohort study.
PubMed 文献 · Anaesthesia · 2020-08-03

该单中心回顾性队列纳入2005至2018年成人非心脏手术全身麻醉维持患者,比较地氟烷(23830例)与七氟烷(84608例)与术后呼吸系统并发症的关系。多变量回归分析显示,地氟烷组术后呼吸系统并发症风险未低于七氟烷组(调整OR 0.99,95%CI 0.94-1.04,p=0.598),各高危亚组及倾向性匹配队列结果一致。

要点

  • 地氟烷与七氟烷相比未降低术后呼吸系统并发症风险。
  • 高危亚组(病态肥胖、老年、高呼吸风险)结果与总体一致。
  • 为挥发性麻醉药的环境与成本决策提供安全性数据支持。

核心结论

  • 与七氟烷相比,地氟烷使用未降低术后呼吸系统并发症风险。

研究设计与样本

  • 单中心回顾性队列分析2005至2018年成人非心脏手术全身麻醉维持患者。
  • 地氟烷组23830例,七氟烷组84608例。
  • 采用多变量回归调整患者、麻醉及手术混杂因素,并进行倾向性匹配、交互及亚组分析。

主要发现

  • 地氟烷组术后呼吸系统并发症风险与七氟烷组无显著差异(调整OR 0.99,95%CI 0.94-1.04,p=0.598)。
  • 病态肥胖(BMI > 35 kg.m-2)、老年(年龄 > 65岁)及高呼吸并发症风险亚组结果与总体一致。
  • 倾向性评分匹配队列结果与主要分析一致。

关键数值与推荐

  • 主要结局定义为拔管后早期血氧饱和度下降(SpO2 < 90%)或术后7天内再插管。
  • 高危亚组定义:病态肥胖BMI > 35 kg.m-2;老年年龄 > 65岁;高呼吸并发症风险。

临床怎么用

  • 在选择地氟烷或七氟烷维持麻醉时,术后呼吸系统并发症风险无显著差异。
  • 可结合环境与成本因素进行麻醉药物选择决策。

局限性

  • 单中心回顾性研究设计。
  • 原文未报告其他局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Sevoflurane and desflurane are the most commonly used volatile anaesthetics for maintenance of anaesthesia. In this study, we aimed to evaluate the relationship between choice of volatile anaesthetic and early postoperative respiratory complications, and to address a critical knowledge gap in safety outcomes between these two commonly used agents. We performed a retrospective analysis of adult (non-cardiac surgery) patients who received sevoflurane or desflurane for the maintenance of general anaesthesia at our institution between 2005 and 2018. We evaluated the association between desflurane exposure (when compared with sevoflurane) and the primary outcome of postoperative respiratory complications, defined by early post-extubation desaturation (Sp O2 < 90%) or re-intubation within 7 days postoperatively. Multivariable regression analyses were performed and adjusted for confounding factors, including patient, anaesthetic and surgical factors. Propensity matched, interaction and sub-group analyses were performed to assess outcomes in high-risk groups: morbidly obese (BMI > 35 kg.m-2 ); elderly (age > 65 years); and high risk of respiratory complications as well as the primary outcome at 24 h. Desflurane was used for 23,830 patients and sevoflurane for 84,608 patients. Patients exposed to desflurane did not demonstrate a reduced risk of postoperative respiratory complications when compared with sevoflurane (adjusted odds ratio 0.99, 95%CI 0.94-1.04, p = 0.598). These findings were consistent across all sub-groups of high-risk patients and in the propensity score matched cohort. In summary, desflurane use was not associated with reduced postoperative respiratory complications when compared with sevoflurane. In the context of environmental and cost concerns with volatile anaesthetic agents, our study provides important data to support organisational decisions regarding the use of desflurane.

来源:Anaesthesia,查看原文。版权归原作者所有。

引用

  1. Zucco L, Santer P, Levy N, et al. A comparison of postoperative respiratory complications associated with the use of desflurane and sevoflurane: a single-centre cohort study. Anaesthesia. 2020. PMID: 32743803. doi:10.1111/anae.15203

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。